ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 57 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,242,289 | +4.4% | 584,955 | 0.0% | 1.36% | -6.3% |
| Q2 2023 | $8,856,219 | +4.4% | 584,955 | 0.0% | 1.45% | -12.2% |
| Q1 2023 | $8,481,848 | +7.2% | 584,955 | 0.0% | 1.65% | +18.4% |
| Q4 2022 | $7,908,592 | -21.9% | 584,955 | -8.9% | 1.40% | -54.0% |
| Q3 2022 | $10,121,000 | +25.2% | 642,189 | -3.2% | 3.04% | -11.6% |
| Q2 2022 | $8,084,000 | +31.8% | 663,694 | 0.0% | 3.43% | +39.5% |
| Q1 2022 | $6,133,000 | -46.0% | 663,694 | 0.0% | 2.46% | -53.7% |
| Q4 2021 | $11,362,000 | – | 663,694 | – | 5.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,750,000 | 26.57% |
| 5AM Venture Management, LLC | 4,408,379 | $69,476,000 | 13.31% |
| 72 Investment Holdings, LLC | 509,023 | $8,022,000 | 6.36% |
| TCG Crossover Management, LLC | 642,189 | $10,121,000 | 3.04% |
| StepStone Group LP | 761,277 | $11,998,000 | 1.71% |
| Nan Fung Group Holdings Ltd | 141,593 | $2,232,000 | 1.42% |
| Redmile Group, LLC | 1,954,419 | $30,802,000 | 1.20% |
| Baker Brothers Advisors | 4,865,819 | $76,685,000 | 0.50% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,655,000 | 0.04% |
| Laurion Capital Management LP | 199,066 | $3,137,000 | 0.02% |